Cargando…
Role of Mitochondrial Markers in Improved Detection and Risk-Stratification in Barrett’s Esophagus Patients
Barrett’s esophagus (BE) is the only known precursor of esophageal adenocarcinoma (EAC) and is amenable to treatment. However, more than 90 percent of EAC patients are never diagnosed with antecedent BE. Identification of molecular markers for BE is needed to improve detection of BE through efficien...
Autores principales: | Grewal, Udhayvir S., Randhawa, Mehraj S., Mehta, Aryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747936/ https://www.ncbi.nlm.nih.gov/pubmed/31543714 |
Ejemplares similares
-
Higher risk of neoplastic progression of Barrett’s esophagus in patients with systemic sclerosis
por: Anilkumar, Mythri, et al.
Publicado: (2021) -
Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007) -
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014) -
Barrett’s esophagus: an exaggerated risk?
por: Bisschops, Raf
Publicado: (2012) -
Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance
por: Gatenby, Piers, et al.
Publicado: (2016)